Clinical Trial Update: An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma

View source ↗

Summary

This entry describes an observational study of Glofitamab in Chinese adults with second-line Diffuse Large B-Cell Lymphoma and notes that the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Glofitamab (glofitamab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diffuse Large B-Cell Lymphoma | Status: RECRUITING